Bartosz Kamil Sobocki
Overview
Explore the profile of Bartosz Kamil Sobocki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kucharski R, Sobocki B, Stachowska E, Bulman N, Kalinowski L, Kazmierczak-Siedlecka K
Front Immunol
. 2025 Feb;
16:1502605.
PMID: 39975550
Ulcerative colitis is a chronic disease that has not well-established etiology. The role of microbial dysregulation in its pathogenesis has been recently highlighted. Overall, microbiome alterations concern the reduction of...
2.
Nowicka Z, Kuna K, Laszczych M, Lazar-Poniatowska M, Sobocki B, Stawiski K, et al.
Phys Imaging Radiat Oncol
. 2024 Jun;
30:100593.
PMID: 38912008
Background And Purpose: Radiation-induced lymphopenia (RIL) is a common side effect of radiotherapy (RT) that may negatively impact survival. We aimed to identify RIL predictors in patients with non-small-cell lung...
3.
De Wilt L, Sobocki B, Jansen G, Tabeian H, de Jong S, Peters G, et al.
Cancer Drug Resist
. 2024 Jun;
7:12.
PMID: 38835345
The therapeutic targeting of the tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) death receptors in cancer, including non-small cell lung cancer (NSCLC), is a widely studied approach for tumor selective...
4.
Kazmierczak-Siedlecka K, Muszynski D, Styburski D, Makarewicz J, Sobocki B, Ulasinski P, et al.
Front Cell Infect Microbiol
. 2024 May;
14:1394038.
PMID: 38774628
Introduction: Recent years, microbiota-associated aspects have been analysed in multiple disorders regarding cancers. Existing evidence pints that gut microorganisms might take part in tumour origin and therapy efficacy. Nevertheless, to...
5.
Makarewicz J, Kazmierczak-Siedlecka K, Sobocki B, Dobrucki I, Kalinowski L, Stachowska E
Front Cell Infect Microbiol
. 2024 Mar;
14:1329057.
PMID: 38481661
Head and neck squamous cell carcinoma (HNSCC) exhibits significant genetic heterogeneity and primarily concerns the oral cavity and oropharynx. These cancers occur more frequently in men with a 5-year survival...
6.
Kazmierczak-Siedlecka K, Bulman N, Ulasinski P, Sobocki B, Polom K, Marano L, et al.
Gut Microbes
. 2023 Nov;
15(2):2281017.
PMID: 37985748
Intestinal bacteria are equipped with an enzyme apparatus that is involved in the active biotransformation of xenobiotics, including drugs. Pharmacomicrobiomics, a new area of pharmacology, analyses interactions between bacteria and...
7.
Dabrowska A, Grubba M, Balihodzic A, Szot O, Sobocki B, Perdyan A
Int J Mol Sci
. 2023 Sep;
24(18).
PMID: 37762416
Despite tremendous progress in cancer treatment in recent years, treatment resistance is still a major challenge for a great number of patients. One of the main causes is regulatory T...
8.
Kudra A, Kazmierczak-Siedlecka K, Sobocki B, Muszynski D, Polom J, Carbone L, et al.
Front Microbiol
. 2023 Aug;
14:1182547.
PMID: 37608943
The gut microbiome has been increasingly understood to play a critical role in carcinogenesis and cancer disease progression. The most recent research advancements have shown that different tools of microbiota...
9.
Perdyan A, Sobocki B, Balihodzic A, Dabrowska A, Kacperczyk J, Rutkowski J
Cancers (Basel)
. 2023 Jul;
15(13).
PMID: 37444600
Despite a great success of immunotherapy in cancer treatment, a great number of patients will become resistant. This review summarizes recent reports on immune checkpoint inhibitor retreatment or rechallenge in...
10.
Kudra A, Muszynski D, Sobocki B, Atzeni A, Carbone L, Kazmierczak-Siedlecka K, et al.
Front Cell Infect Microbiol
. 2023 May;
13:1159822.
PMID: 37124035
Microbiome is a keystone polymicrobial community that coexist with human body in a beneficial relationship. These microorganisms enable the human body to maintain homeostasis and take part in mechanisms of...